Heart-gut axis: Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) to prevent cardiovascular disease through gut microbiota

Hillman, 2017, Microbial ecology along the gastrointestinal tract, Microb Environ, 32, 300, 10.1264/jsme2.ME17017 Kolodziejczyk, 2019, Diet-microbiota interactions and personalized nutrition, Nat Rev Microbiol, 17, 742, 10.1038/s41579-019-0256-8 Turnbaugh, 2007, The human microbiome project, Nature, 449, 804, 10.1038/nature06244 Illiano, 2020, The mutual interplay of gut microbiota, diet and human diseas, FEBS J, 287, 833, 10.1111/febs.15217 Dekaboruah, 2020, Human microbiome: an academic update on human body site specific surveillance and its possible role, Arch Microbiol, 202, 2147, 10.1007/s00203-020-01931-x Zabell, 2017, Targeting the microbiome in heart failure, Curr Treat Options Cardiovasc Med, 19, 27, 10.1007/s11936-017-0528-4 Tang, 2019, Intestinal microbiota in cardiovascular health and disease: JACC State-of-the-Art Review, J Am Coll Cardiol, 73, 2089, 10.1016/j.jacc.2019.03.024 Shimada, 2015, PCSK9 Proprotein convertase subtilisin/kexin type inhibitors: past, present, and the future, Eur Heart J, 36, 2415, 10.1093/eurheartj/ehv174 Bergeron, 2015, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk, Circulation, 132, 1648, 10.1161/CIRCULATIONAHA.115.016080 Altamirano, 2015, Cardio-protection in ischaemia-reperfusion injury: novel mechanisms and clinical translation, J Physiol, 593, 3773, 10.1113/JP270953 Płociennikowska, 2015, Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling, Cell Mol Life Sci, 72, 557, 10.1007/s00018-014-1762-5 Villette, 2020, Unraveling host-gut microbiota dialogue and its impact on cholesterol Levels, Front Pharmacol, 11, 10.3389/fphar.2020.00278 Morelli, 2019, Functional role of gut microbiota and PCSK9 in the pathogenesis of diabetes mellitus and cardiovascular disease, Atherosclerosis, 289, 176, 10.1016/j.atherosclerosis.2019.07.023 Carmody, 2015, Diet dominates host genotype in shaping the murine gut microbiota, Cell Host Microbe, 17, 72, 10.1016/j.chom.2014.11.010 Tamburini, 2016, The microbiome in early life: implications for health outcome, Nat Med, 22, 713, 10.1038/nm.4142 Senghor, 2018, Gut microbiota diversity according to dietary habits and geographical provenance, Human Microbiome Journal, 7–8, 1, 10.1016/j.humic.2018.01.001 Luthra-Guptasarma, 2020 Qin, 2010, A human gut microbial gene catalogue established by metagenomic sequencing, Nature, 464, 59, 10.1038/nature08821 Kedia, 2016, Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India, J Gastroenterol, 51, 660, 10.1007/s00535-016-1193-1 Sender, 2016, Revised estimates for the number of human and bacteria cells in the body, PLoS Biol, 14, 10.1371/journal.pbio.1002533 Miele, 2015, Impact of gut microbiota on obesity, diabetes and cardiovascular disease risk, Curr Cardiol Rep, 17 Leeming, 2019, Effect of diet on the gut microbiota: rethinking intervention duration, Nutrients, 11, 2862, 10.3390/nu11122862 Williamson, 2017, The role of polyphenols in modern nutrition, Nutr Bull, 42, 226, 10.1111/nbu.12278 Correa, 2019, The two-way polyphenols-microbiota interactions and their effects on obesity and related metabolic diseases, Front Nutr, 6, 188, 10.3389/fnut.2019.00188 Yang, 2020, Role of dietary nutrients in the modulation of gut microbiota: a narrative review, Nutrients, 2, 381, 10.3390/nu12020381 Chen, 2016, An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis, Genome Med, 8, 43, 10.1186/s13073-016-0299-7 Vrieze, 2012, Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome, Gastroenterology, 143, 913, 10.1053/j.gastro.2012.06.031 Cui, 2017, Association study of gut flora in coronary heart disease through high throughput sequencing, BioMed Res Int, 10.1155/2017/3796359 Luedde, 2017, Heart failure is associated with depletion of core intestinal microbiota, ESC Heart Fail, 4, 282, 10.1002/ehf2.12155 Jie, 2017, The gut microbiome in atherosclerotic cardiovascular disease, Nat Commun, 1 Chen, 2019, Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure, Chin Med J, 132, 1843, 10.1097/CM9.0000000000000330 Karlsson, 2012, Symptomatic atherosclerosis is associated with an altered gut metagenome, Na Commun, 3, 1245, 10.1038/ncomms2266 Rogha, 2012, Is Helicobacter pylori infection a risk factor for coronary heart disease?, ARYA Atherosclerosis, 8, 5 Li, 2016, Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in ApoE -/- mice, Circulation, 133, 2434, 10.1161/CIRCULATIONAHA.115.019645 Rezaie, 2016, How to test and treat small intestinal bacterial overgrowth: an evidence-based approach, Curr Gastroenterol Rep, 18, 8, 10.1007/s11894-015-0482-9 Fialho, 2018, Association between small intestinal bacterial overgrowth by glucose breathe test and coronary artery disease, Dig Dis Sci, 63, 412, 10.1007/s10620-017-4828-z Adike, 2018, Small intestinal bacterial overgrowth: nutritional implications, diagnosis and management, Gastroenterol Clin N Am, 47, 193, 10.1016/j.gtc.2017.09.008 Khosravi, 2014, Gut microbiota promote hematopoiesis to control bacterial infection, Cell Host Microbe, 15, 374, 10.1016/j.chom.2014.02.006 Zaid, 2008, Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration, Hepatology, 48, 646, 10.1002/hep.22354 Seidah, 2018, The ever-expanding saga of the proprotein convertases and their roles in body homeostasis: emphasis on novel proprotein convertase subtilisin kexin number 9 functions and regulation, Curr Opin Lipidol, 29, 144, 10.1097/MOL.0000000000000484 Li, 2020, A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in, Taiwania, 119, 674 2016, GBD-2015 Mortality and causes of death collaborators: global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study, Lancet, 388, 1459, 10.1016/S0140-6736(16)31012-1 Mozaffarian, 2015, Heart disease and stroke statistics-2015 update: a report from the American Heart Association, Circulation, 131, e29 Singh, 2018, The gut, brain, and heart connection, World Heart J, 3, 151 Kamo, 2017, Novel Concept of a heart-gut axis in the pathophysiology of heart failure, Korean Circ J, 4, 663, 10.4070/kcj.2017.0028 Ouguerram, 2004, Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9, Arterioscler Thromb Vasc Biol, 24, 1448, 10.1161/01.ATV.0000133684.77013.88 Ahmadmehrabi, 2017, Gut microbiome and its role in cardiovascular diseases, Curr Opin Cardiol, 32, 761, 10.1097/HCO.0000000000000445 Cui, 2018, Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients, Sci Rep, 8, 635, 10.1038/s41598-017-18756-2 Koren, 2011, Human oral, gut, and plaque microbiota in patients with atherosclerosis, Proc Natl Acad Sci USA, 108, 4592, 10.1073/pnas.1011383107 Cariou, 2015, Role of PCSK9 beyond liver involvement, Curr Opin Lipidol, 26, 155, 10.1097/MOL.0000000000000180 Norata, 2014, Targeting PCSK9 for hypercholesterolemia, Annu Rev Pharmacol Toxicol, 54, 273, 10.1146/annurev-pharmtox-011613-140025 Lee, 2019, PCSK9 is increased in cerebrospinal fluid of individuals with alcohol use disorder, Alcohol Clin Exp Res, 43, 1163, 10.1111/acer.14039 Cohen, 2006, Sequence variations in PCSK9, low LDL and protection against coronary heart disease, N Engl J Med, 354, 1264, 10.1056/NEJMoa054013 Cariou, 2016, PCSK9 and atherosclerosis: beyond LDL-cholesterol lowering, Atherosclerosis, 253, 275, 10.1016/j.atherosclerosis.2016.08.007 Cariou, 2013, Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets, Nutr Metab, 10, 4, 10.1186/1743-7075-10-4 Graversen, 2016, Marine n-3 polyunsaturated fatty acids lower plasma proprotein convertase subtilisin kexin type 9 levels in pre- and postmenopausal women: a randomized study, Vasc Pharmacol, 76, 37, 10.1016/j.vph.2015.07.001 Krysa, 2017, Nutritional and lipid modulation of PCSK9: effects on cardiometabolic risk factors, J Nutr, 147, 473 Le May, 2013, Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1, Arterioscler Thromb Vasc Biol, 33, 1484, 10.1161/ATVBAHA.112.300263 Pastori, 2019, Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: a post-hoc analysis from the ATHERO-AF cohort, Atherosclerosis, 289, 195, 10.1016/j.atherosclerosis.2019.07.002 Brandsma, 2019, A Proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis, Circ Res, 124, 94, 10.1161/CIRCRESAHA.118.313234 Abifadel, 2003, Mutations in PCSK9 cause autosomal dominant hypercholesterolemia, Nat Genet, 34, 154, 10.1038/ng1161 Desai, 2015, PCSK9 inhibition in patients with hypercholesterolemia, Trends Cardiovasc Med, 25, 567, 10.1016/j.tcm.2015.01.009 Dullaart, 2017, PCSK9 inhibition to reduce cardiovascular events, N Engl J Med, 376, 1790, 10.1056/NEJMe1703138 Ding, 2018, PCSK9 expression in the ischemic heart and its relationship to infarct size, cardiac function, and development of autophagy, Cardiovasc Res, 114, 1738, 10.1093/cvr/cvy128 Wu, 2019, Identification of TMAO-producer phenotype and host–diet–gut dysbiosis by carnitine challenge test in human and germ-free mice, Gut, 68, 1439, 10.1136/gutjnl-2018-317155 Bennett, 2013, Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation, Cell Metabol, 17, 49, 10.1016/j.cmet.2012.12.011 Tilg, 2015, Food, immunity, and the microbiome, Gastroenterol, 148, 1107, 10.1053/j.gastro.2014.12.036 Brown, 2015, The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases, Annu Rev Med, 66, 343, 10.1146/annurev-med-060513-093205 Roncal, 2017, Trimethylamine-N-Oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease, J Am Heart Assoc, 29 Li, 2017, Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors, Eur Heart J, 38, 814 Heianza, 2017, Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies, J Am Heart Assoc, 6 Morrison, 2016, Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism, Gut Microb, 7, 189, 10.1080/19490976.2015.1134082 Calderon-Perez, 2020, Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study, Sci Rep, 10, 6436, 10.1038/s41598-020-63475-w Sayin, 2013, Gut microbiota regulates bile acid metabolism by reducing the levels of taurobeta-muricholic acid, a naturally occurring FXR antagonist, Cell Metabol, 17, 225, 10.1016/j.cmet.2013.01.003 Begley, 2005, The interaction between bacteria and bile, FEMS Microbiol Rev, 29, 625, 10.1016/j.femsre.2004.09.003 Devlin, 2016, Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota, Cell Host Microbe, 20, 709, 10.1016/j.chom.2016.10.021 Romano, 2015, Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide, mBio, 6, 10.1128/mBio.02481-14 Gajarsa, 2011, Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities, Heart Fail Rev, 16, 13, 10.1007/s10741-010-9181-7 Zhu, 2018, Dysbiosis signatures of gut microbiota in coronary artery disease, Physiol Genom, 50, 893, 10.1152/physiolgenomics.00070.2018 Sathe, 2014, MicroRNA let-7f: a novel regulator of innate immune response in human endocervical cells, Am J Reprod Immunol, 71, 137, 10.1111/aji.12165 Neish, 2009, Microbes in gastrointestinal health and disease, Gastroenterology, 136, 65, 10.1053/j.gastro.2008.10.080 Larsson, 2012, Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88, Gut, 61, 1124, 10.1136/gutjnl-2011-301104 Walley, 2014, PCSK9 is a critical regulator of the innate immune response and septic shock outcome, Sci Transl Med, 6, 258ra143, 10.1126/scitranslmed.3008782 Ding, 2016, Cross-talk between PCSK9 and damaged mtDNA in vascular smooth muscle cells: role in apoptosis, Antioxidants Redox Signal, 25, 997, 10.1089/ars.2016.6631 Li, 2014, Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease, Atherosclerosis, 234, 441, 10.1016/j.atherosclerosis.2014.04.001 Yuan, 2009, LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection, Am J Physiol Heart Circ Physiol, 296, H470, 10.1152/ajpheart.01051.2008 Liu, 2018, PCSK9 plays a novel immunological role in oxidized LDL-induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque, J Intern Med, 284, 193, 10.1111/joim.12758 Kim, 2019, A critical role of PCSK9 in mediating IL-17-producing T cell responses in hyperlipidemia, Immune Netw, 19, e41, 10.4110/in.2019.19.e41 De Filippis, 2016, High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome, Gut, 65, 1812, 10.1136/gutjnl-2015-309957 Arumugam, 2011, Enterotypes of the human gut microbiome, Nature, 473, 174, 10.1038/nature09944 Hill, 2014, Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat Rev Gastroenterol Hepatol, 11, 506, 10.1038/nrgastro.2014.66 Gan, 2014, Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat, Circ Heart Fail, 7, 491, 10.1161/CIRCHEARTFAILURE.113.000978 Costanza, 2015, Probiotic therapy with saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial, Int J Cardiol, 179, 348, 10.1016/j.ijcard.2014.11.034 Gibson, 2017, Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics, Nat Rev Gastroenterol Hepatol, 14, 491, 10.1038/nrgastro.2017.75 DeFilipp, 2019, Drug-Resistant E. coli bacteremia transmitted by fecal microbiota transplant, N Engl J Med, 381, 2043, 10.1056/NEJMoa1910437 W, 2015, Dietary allicin reduces transformation of l-carnitine to TMAO through impact on gut microbiota, J Funct Foods, 15, 408 Manzini, 2018, Topiramate protects ApoE -/- deficient mice from kidney damage without affecting plasma lipids, Pharmacol Res, 141, 189, 10.1016/j.phrs.2018.12.022 Wang, 2015, Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis, Cell, 163, 1585, 10.1016/j.cell.2015.11.055